Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.
Jones SM, Mann A, Conrad K, Saum K, Hall DE, McKinney LM, Robbins N, Thompson J, Peairs AD, Camerer E, Rayner KJ, Tranter M, Mackman N, Owens AP 3rd. Jones SM, et al. Among authors: tranter m. Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1271-1282. doi: 10.1161/ATVBAHA.117.310082. Epub 2018 Mar 29. Arterioscler Thromb Vasc Biol. 2018. PMID: 29599135 Free PMC article.
The history and future of probenecid.
Robbins N, Koch SE, Tranter M, Rubinstein J. Robbins N, et al. Among authors: tranter m. Cardiovasc Toxicol. 2012 Mar;12(1):1-9. doi: 10.1007/s12012-011-9145-8. Cardiovasc Toxicol. 2012. PMID: 21938493 Review.
Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.
Koch SE, Tranter M, Robbins N, Luther K, Singh U, Jiang M, Ren X, Tee T, Smith L, Varma P, Jones WK, Rubinstein J. Koch SE, et al. Among authors: tranter m. J Cardiovasc Pharmacol Ther. 2013 May;18(3):280-9. doi: 10.1177/1074248412469299. Epub 2012 Dec 14. J Cardiovasc Pharmacol Ther. 2013. PMID: 23241275 Free PMC article.
Tranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 Channels.
Koch SE, Nieman ML, Robbins N, Slone S, Worley M, Green LC, Chen Y, Barlow A, Tranter M, Wang H, Lorenz JN, Rubinstein J. Koch SE, et al. Among authors: tranter m. J Cardiovasc Pharmacol. 2018 Jul;72(1):40-48. doi: 10.1097/FJC.0000000000000588. J Cardiovasc Pharmacol. 2018. PMID: 29688911 Free PMC article.
Tefillin use induces remote ischemic preconditioning pathways in healthy men.
Owens AP 3rd, Robbins N, Saum K, Jones SM, Kirschner A, Woo JG, McCoy C, Slone S, Rothenberg ME, Urbina EM, Tranter M, Rubinstein J. Owens AP 3rd, et al. Among authors: tranter m. Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1748-H1758. doi: 10.1152/ajpheart.00347.2018. Epub 2018 Sep 14. Am J Physiol Heart Circ Physiol. 2018. PMID: 30216115 Free PMC article.
Human antigen R as a therapeutic target in pathological cardiac hypertrophy.
Green LC, Anthony SR, Slone S, Lanzillotta L, Nieman ML, Wu X, Robbins N, Jones SM, Roy S, Owens AP 3rd, Aube J, Xu L, Lorenz JN, Blaxall BC, Rubinstein J, Benoit JB, Tranter M. Green LC, et al. Among authors: tranter m. JCI Insight. 2019 Feb 21;4(4):e121541. doi: 10.1172/jci.insight.121541. eCollection 2019 Feb 21. JCI Insight. 2019. PMID: 30668549 Free PMC article.
Adipocyte-specific deletion of HuR induces spontaneous cardiac hypertrophy and fibrosis.
Guarnieri AR, Anthony SR, Gozdiff A, Green LC, Fleifil SM, Slone S, Nieman ML, Alam P, Benoit JB, Owens AP, Kanisicak O, Tranter M. Guarnieri AR, et al. Among authors: tranter m. Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H228-H241. doi: 10.1152/ajpheart.00957.2020. Epub 2021 May 21. Am J Physiol Heart Circ Physiol. 2021. PMID: 34018851 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 35556911
106 results